Digest

• Indian stock markets closed today for the Ganesh Chaturthi holiday, pausing updates for the Nifty 50 and Sensex. • The National Company Law Tribunal will hear the proposed merger of Piombino Steel into JSW Steel on 24 September. • Market closures prevent active trading and real-time price updates for retail and institutional investors today.

• The Election Commission of India met with two rival factions of the Trinamool Congress on September 12, 2026, to resolve a dispute over the party's name and symbol. • The poll body requested additional documentation from the faction led by State Assembly Leader of Opposition Ritabrata Banerjee. • This decision affects the legal identity and branding of the political party during upcoming electoral processes.

• Market expectations for a Federal Reserve interest rate hike on September 16 shifted toward a base case following new inflation data. • August core CPI rose 0.3% month-over-month, pushing CME odds of a 25 basis point hike from 59.4% a week ago to 86.5% after the release. • Rising yields in high-debt nations like the US, UK, and France suggest that fiscal risk is driving market volatility more than in low-debt countries.

• North Korea fired an unidentified projectile toward the Sea of Japan on Saturday, September 12, 2026. • South Korea's Joint Chiefs of Staff reported the launch via the Yonhap News Agency. • This military activity increases regional tension for governments and markets in East Asia.

• Japan plans to use official development assistance to upgrade fishing ports in Indonesia to support coast guard patrol vessel stops. • Japanese government sources announced the plan on Sunday, September 6, 2026. • This initiative strengthens maritime security and infrastructure cooperation between Japan and the Southeast Asian nation.

• Scientists discovered that human microglia, the immune cells responsible for shaping developing brain circuits, take four to eight years to mature. • This maturation period is significantly longer than the few weeks required for the same process in mice. • This finding suggests that brain development in humans occurs over a much longer timeframe than previously assumed based on animal models.

• The FDA has approved Oveporexton (brand name Orzeyful), developed by Takeda, for the treatment of narcolepsy type 1 in adults. • As the first drug to directly restore orexin signaling, the twice-daily tablet demonstrated improvements in daytime sleepiness, cataplexy, sleep paralysis, and hallucinations across two clinical trials. • The approval follows the drug's receipt of FDA Breakthrough Therapy designation and Priority Review, addressing the core biological deficit of the disorder.